Coronavirus News Roundup: COVID-19 Therapy Pipeline Update, FDA Boosts Max Doses in Vials of Moderna Vaccine
Here's the roundup of COVID-19 related news from this week.
The COVID-19 vaccination effort is picking up the pace in the US, with over 174.88 million administered doses and 19.8% of the population fully vaccinated against the virus as of April 1.
Here’s a roundup of the latest coronavirus-related news, including the FDA’s update of Moderna’s COVID-19 vaccine and featuring a COVID-19 therapy pipeline update from the April issue of Drug Topics® Journal.
Independent Pharmacy’s Best Kept Secret in Administering COVID-19 Vaccines
Stories about independent pharmacies not offering COVID-19 vaccines have flooded the local media in places like Philadelphia, Pennsylvania, and Colorado, but a different story is being told on the East and West coasts.
Leverage Community Pharmacies Now and in the Next Phases of COVID-19 Vaccination
In this expert interview, Rich Tremonte, executive vice president and president of community and specialty pharmacy at AmerisourceBergen, discusses some key insights on the COVID-19 vaccine rollout.
FDA Boosts Maximum Doses in Vials of Moderna COVID-19 Vaccines
A recent FDA announcement has clarified important dosage information for the 2 types of vials for the Moderna COVID-19 vaccine and stated that it will allow Moderna to offer vials with even more doses.
Optimize Pharmacy Technician Roles In Immunization, Patient Care Services
As COVID-19 vaccination demands and dissemination expands, how is your pharmacy succeeding? How can you stay on track for success? Our upcoming webinar discusses how effective integration of Certified Pharmacy Technicians (CPhTs) into pharmacy workflows can lead to optimal patient care and improved business outcomes.
Register for the April 14 webinar
Migraine Treatments Do Not Affect COVID-19 Vaccine Immunogenicity
Experts discussed clinical questions regarding migraine treatments and COVID-19 vaccines.
COVID-19 Therapy Pipeline Update
The treatment landscape for patients with COVID-19 infections is constantly evolving, particularly as new information related to the disease is identified. Here is a current glance at several agents under investigation to keep you up-to-date with the latest advancements.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
